Contrast-enhanced Ultrasound (CEUS) Follow-up After Radiofrequency Ablation or Cryoablation of Focal Liver Lesions: Treated-area Patterns and Their Changes over Time
Overview
Authors
Affiliations
Objectives: To describe the early patterns of liver lesions successfully treated with radiofrequency ablation (RFA) or cryoablation (CA) and their changes over time.
Methods: Twenty-two RFA-treated and 17 CA-treated patients underwent CEUS from week 1 to year 3 post-ablation. Patterns, margins and volumes of RF-induced and cryolesions were evaluated and compared over time.
Results: After contrast enhancement, shortly after ablation, undefined margins with persistent enhancing small vessels penetrating >2 mm into the treated zone were significantly more frequent after CA (67 %) than RFA (22 %) (P < 0.02). During the arterial phase, a thin, enhancing marginal rim was seen during week 1 (T1) in around 28 % of RF lesions, while 75 % of cryolesions had thick enhancing rims (P < 0.02). The mean RF-induced lesion volume, maximum at T1 (44.1 ± 37.5 ml), shrank slowly over time, remaining clearly visible at 1 year (8.3 ± 7.4 ml). Cryolesions shrank faster (P = 0.009), from an average of 16.6 ± 7.1 ml at T1 to 1.7 ± 1.3 ml 1-year post-ablation.
Conclusion: RF-induced and cryolesions differ, particularly their margins and shrinkage rates. Knowing these differences allows avoidance of incomplete treatment or falsely diagnosed recurrence, especially after CA.
Key Points: • Contrast-enhanced ultrasound (CEUS) provides new follow-up information following hepatic radiological inyervention. • CEUS provides good visualisation of vascular modifications after thermoablation. • RFA-induced lesions and cryoablated lesions differ. • Knowledge about RF and cryolesion patterns is essential for correct CEUS follow-up. • Cryolesions have thicker peripheral inflammatory reactions and shrink faster than RFA-induced lesions.
Wade R, South E, Anwer S, Sharif-Hurst S, Harden M, Fulbright H Health Technol Assess. 2023; 27(29):1-172.
PMID: 38149643 PMC: 11017143. DOI: 10.3310/GK5221.
Wang Y, De Leon A, Perera R, Abenojar E, Gopalakrishnan R, Basilion J Sci Rep. 2021; 11(1):4726.
PMID: 33633232 PMC: 7907080. DOI: 10.1038/s41598-021-84072-5.
Zhou L, Yin S, Chai W, Zhao Q, Tian G, Xu D World J Surg Oncol. 2020; 18(1):305.
PMID: 33228665 PMC: 7684738. DOI: 10.1186/s12957-020-02083-4.
Hawkins C, Towbin A, Roebuck D, Monroe E, Gill A, Thakor A Pediatr Radiol. 2018; 48(4):565-580.
PMID: 29396792 DOI: 10.1007/s00247-018-4072-5.
Contrast-enhanced ultrasonography of the liver using SonoVue.
Ferraioli G, Meloni M Ultrasonography. 2017; 37(1):25-35.
PMID: 28830058 PMC: 5769944. DOI: 10.14366/usg.17037.